{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:39:20Z","timestamp":1794886760120,"version":"4.9.1"},"reference-count":39,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Joint arthropathy secondary to recurrent hemarthroses remains a debilitating complication of hemophilia despite the use of prophylactic factor concentrates. Increased vascularity and neoangiogenesis have been implicated in the progression of musculoskeletal disorders and tumor growth. We hypothesized that de novo blood vessel formation could play a major role in the pathogenesis of hemophilic joint disease (HJD). We observed a 4-fold elevation in proangiogenic factors (vascular endothelial growth factor-A [VEGF-A], stromal cell\u2013derived factor-1, and matrix metalloprotease-9) and proangiogenic macrophage\/monocyte cells (VEGF+\/CD68+ and VEGFR1+\/CD11b+) in the synovium and peripheral blood of HJD subjects along with significantly increased numbers of VEGFR2+\/AC133+ endothelial progenitor cells and CD34+\/VEGFR1+ hematopoietic progenitor cells. Sera from HJD subjects induced an angiogenic response in endothelial cells that was abrogated by blocking VEGF, whereas peripheral blood mononuclear cells from HJD subjects stimulated synovial cell proliferation, which was blocked by a humanized anti-VEGF antibody (bevacizumab). Human synovial cells, when incubated with HJD sera, could elicit up-regulation of HIF-1\u03b1 mRNA with HIF-1\u03b1 expression in the synovium of HJD subjects, implicating hypoxia in the neoangiogenesis process. Our results provide evidence of local and systemic angiogenic response in hemophilic subjects with recurrent hemarthroses suggesting a potential to develop surrogate biologic markers to identify the onset and progression of hemophilic synovitis.<\/jats:p>","DOI":"10.1182\/blood-2010-05-284653","type":"journal-article","created":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T03:26:25Z","timestamp":1292556385000},"page":"2484-2493","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":108,"title":["Neoangiogenesis contributes to the development of hemophilic synovitis"],"prefix":"10.1182","volume":"117","author":[{"given":"Suchitra S.","family":"Acharya","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, National Institutes of Health, Bethesda, MD;"},{"name":"Pediatric Hematology\/Oncology\/BMT Cohen Children's Medical Center of New York, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosandra N.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, National Institutes of Health, Bethesda, MD;"},{"name":"Cell and Developmental Biology, Weill Cornell Medical College, New York, NY;"},{"name":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, National Institutes of Health, Bethesda, MD;"},{"name":"Cell and Developmental Biology, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwa T.","family":"Fabiyi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, National Institutes of Health, Bethesda, MD;"},{"name":"Cell and Developmental Biology, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"DiMichele","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, National Institutes of Health, Bethesda, MD;"},{"name":"National Heart Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lyden","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, National Institutes of Health, Bethesda, MD;"},{"name":"Cell and Developmental Biology, Weill Cornell Medical College, New York, NY;"},{"name":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111808263671400_B1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-2004-815626","article-title":"Advances in care of children with hemophilia.","volume":"29","author":"Manco-Johnson","year":"2003","journal-title":"Semin Thromb Haemost"},{"key":"2019111808263671400_B2","first-page":"6","article-title":"Pathogenesis, early diagnosis and prophylaxis for chronic hemophilic synovitis.","volume":"343","author":"Rodriguez-Merchan","year":"1997","journal-title":"Clin Orthop"},{"key":"2019111808263671400_B3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminhematol.2005.11.026","article-title":"Pathogenesis of hemophilia arthropathy.","volume":"43","author":"Hoots","year":"2006","journal-title":"Semin Hematol"},{"issue":"9","key":"2019111808263671400_B4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/art.1780310910","article-title":"Mechanisms of joint damage in an experimental model of hemophilic arthritis.","volume":"31","author":"Madhok","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2019111808263671400_B5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111808263671400_B6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2516.2000.00406.x","article-title":"Isotopic synovectomy with P-32 in paediatric patients with haemophilia.","volume":"6","author":"Mathew","year":"2000","journal-title":"Haemophilia"},{"issue":"3","key":"2019111808263671400_B7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2516.2007.01539.x","article-title":"Arthroscopic synovectomy in hemophilia: indications, techniques and results.","volume":"13","author":"Verma","year":"2007","journal-title":"Haemophilia"},{"issue":"3","key":"2019111808263671400_B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2516.2000.00383.x","article-title":"MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage.","volume":"6","author":"Nuss","year":"2000","journal-title":"Haemophilia"},{"issue":"2","key":"2019111808263671400_B9","first-page":"339","article-title":"Blood-induced joint damage: long term effects in vitro and in vivo.","volume":"30","author":"Hooiveld","year":"2003","journal-title":"J Rheumatol"},{"issue":"3","key":"2019111808263671400_B10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2516.2005.01080.x","article-title":"Synovitis in a murine model of human FVIII deficiency.","volume":"11","author":"Hakobyan","year":"2005","journal-title":"Haemophilia"},{"issue":"7","key":"2019111808263671400_B11","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2003-12-4231","article-title":"Pathobiology of hemophilic synovitis: I. Overexpression of mdm2 oncogene.","volume":"104","author":"Hakobyan","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111808263671400_B12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood-2002-02-0390","article-title":"C-myc protooncogene expression in hemophilic synovitis: in vitro studies on the effects of iron and ceramide.","volume":"100","author":"Wen","year":"2002","journal-title":"Blood"},{"issue":"16","key":"2019111808263671400_B13","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","article-title":"Angiogenesis.","volume":"267","author":"Folkman","year":"1992","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111808263671400_B14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2007-1003526","article-title":"Endothelial cell growth factors and the vessel wall.","volume":"13","author":"Joseph-Silverstein","year":"1987","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2019111808263671400_B15","first-page":"1215","article-title":"Systemic activation of the vascular endothelial growth factor receptor KDR\/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.","volume":"151","author":"Ortega","year":"1997","journal-title":"Am J Pathol"},{"issue":"38","key":"2019111808263671400_B16","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1, but not Flk-1\/KDR, is upregulated by hypoxia.","volume":"272","author":"Gerber","year":"1997","journal-title":"J Biol Chem"},{"issue":"7","key":"2019111808263671400_B17","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/art.20506","article-title":"Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis.","volume":"50","author":"Ruger","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2019111808263671400_B18","first-page":"2244","article-title":"Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.","volume":"26","author":"Maeno","year":"1999","journal-title":"J Rheumatol"},{"issue":"1","key":"2019111808263671400_B19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jhsa.2007.09.002","article-title":"Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis.","volume":"33","author":"Sivakumar","year":"2008","journal-title":"J Hand Surg Am"},{"issue":"4","key":"2019111808263671400_B20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2516.2008.01689.x","article-title":"Experimental hemophilic arthropathy in a mouse model of a massive hemarthrosis: gross, radiological, and histological changes.","volume":"14","author":"Hakobyan","year":"2008","journal-title":"Haemophilia"},{"issue":"1","key":"2019111808263671400_B21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1011066408283","article-title":"Extravasation of poly(amidoamine)(PAMAM) dendrimers across microvascular network endothelium.","volume":"18","author":"El-Sayed","year":"2001","journal-title":"Pharm Res"},{"issue":"6","key":"2019111808263671400_B22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.leu.2404203","article-title":"Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.","volume":"20","author":"Karajannis","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"2019111808263671400_B23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.24288","article-title":"Different amplifying mechanisms of interleukin-17 and interferon G in Fc G-receptor mediated cartilage destruction in murine immune complex-mediated arthritis.","volume":"60","author":"Greevers","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7069","key":"2019111808263671400_B24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"5","key":"2019111808263671400_B25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"issue":"2","key":"2019111808263671400_B26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/scd.2006.15.260","article-title":"Overexpression of stromal cell-derived factor-1 enhances endothelium-supported transmigration, maintenance, and proliferation of hematopoietic progenitor cells.","volume":"15","author":"Hwang","year":"2006","journal-title":"Stem Cells Dev"},{"issue":"11","key":"2019111808263671400_B27","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impairment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"issue":"5860","key":"2019111808263671400_B28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.1150224","article-title":"Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.","volume":"319","author":"Gao","year":"2008","journal-title":"Science"},{"issue":"5","key":"2019111808263671400_B29","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.171.5.2637","article-title":"M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes.","volume":"171","author":"Eubank","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"2019111808263671400_B30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1160\/TH03-06-0378","article-title":"Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation.","volume":"91","author":"Yang","year":"2004","journal-title":"Thromb Haemost"},{"issue":"8","key":"2019111808263671400_B31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat Med"},{"issue":"5","key":"2019111808263671400_B32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/1529-0131(199905)42:5<1033::AID-ANR24>3.0.CO;2-#","article-title":"Blood-induced joint damage: a canine in vivo study.","volume":"42","author":"Roosendaal","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2019111808263671400_B33","first-page":"620","article-title":"Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.","volume":"34","author":"Bresnihan","year":"2007","journal-title":"J Rheumatol"},{"issue":"1","key":"2019111808263671400_B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1679\/aohc.63.17","article-title":"Morphology and functional roles of synoviocytes in the joint.","volume":"63","author":"Iwanaga","year":"2000","journal-title":"Arch Histol Cytol"},{"issue":"9","key":"2019111808263671400_B35","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2","article-title":"Raised serum vascular growth factor levels are associated with destructive change in inflammatory arthritis.","volume":"44","author":"Ballara","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2019111808263671400_B36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/cimm.1995.9978","article-title":"Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470 in combination with cyclosporine: reduction of vascular endothelial growth factor.","volume":"166","author":"Oliver","year":"1995","journal-title":"Cell Immunol"},{"issue":"2","key":"2019111808263671400_B37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ygyno.2006.03.058","article-title":"Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.","volume":"103","author":"Heffler","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"11","key":"2019111808263671400_B38","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","article-title":"The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34 (-) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice.","volume":"95","author":"Peled","year":"2000","journal-title":"Blood"},{"issue":"13","key":"2019111808263671400_B39","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1182\/blood.V96.13.4152","article-title":"Stromal-derived factor-1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.","volume":"96","author":"Lane","year":"2000","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/8\/2484\/1496023\/zh800811002484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/8\/2484\/1496023\/zh800811002484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T19:40:02Z","timestamp":1637005202000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/8\/2484\/28405\/Neoangiogenesis-contributes-to-the-development-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,2,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2010-05-284653","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}